investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Suzanne A Fuqua
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mitch Dowsett
Royal Marsden Hospital
London, United Kingdom
Suzanne A Fuqua
Dan L. Duncan Cancer Center
Waco, United States
Related projects
Georgios Giamas
Compound Screening for the Identification of LMTK3 Kinase-Inhibitors
Breast
Thomas Sayers
Mechanisms of Immune-mediated Tumor Cell Destruction
Breast
Robert A Gatenby
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
Breast
Dario Marchetti
Functional characterization of brain-colonizing breast cancer CTC subsets
Breast
Colleen Ann Sweeney
LRIG Proteins in Mammary gland Development and Carcinogenesis
Breast
Richard A Anderson
PI Signaling Role in Epithelial/Mesenchymal Transition
Breast
Bisrat G Debeb
Elucidate the role of miR-141 in brain metastasis from breast cancer
Breast
David Ross
Biochemical and Molecular Studies on NQO1. Design of Less Toxic Hsp90 Inhibitors
Breast
Targeted Epigenetic Therapy of Triple-Negative Breast Cancer
Breast